Search Results - "MING, Michael E"

Commentary: The quest for an improved risk stratification tool for patients with melanoma by Ming, Michael E., MD, MSCE

Get full text

Cutaneous autoimmune effects in the setting of therapeutic immune checkpoint inhibition for metastatic melanoma by Mochel, Mark C., Ming, Michael E., Imadojemu, Sotonye, Gangadhar, Tara C., Schuchter, Lynn M., Elenitsas, Rosalie, Payne, Aimee S., Chu, Emily Y.

“…Therapeutic immune checkpoint blockade for metastatic melanoma has been associated with vitiligo, pruritus and morbilliform eruptions. Reports of other…”
Get full text

Identification of High-Risk Patients Among Those Diagnosed With Thin Cutaneous Melanomas by GIMOTTY, Phyllis A, ELDER, David E, GUERRY, Dupont, FRAKER, Douglas L, BOTBYL, Jeffrey, SELLERS, Kimberly, ELENITSAS, Rosalie, MING, Michael E, SCHUCHTER, Lynn, SPITZ, Francis R, CZERNIECKI, Brian J

“…Most patients with melanoma have microscopically thin (< or = 1 mm) primary lesions and are cured with excision. However, some develop metastatic disease that…”
Get full text

Assessment of smartphone applications for total body digital photography-guided skin exams by patients by Marek, Andrew J., MS, Chu, Emily Y., MD, PhD, Ming, Michael E., MD, MSCE, Kovarik, Carrie L., MD

Get full text

Thin Primary Cutaneous Malignant Melanoma: A Prognostic Tree for 10-Year Metastasis Is More Accurate Than American Joint Committee on Cancer Staging by Gimotty, Phyllis A, Guerry, DuPont, Ming, Michael E, Elenitsas, Rosalie, Xu, Xiaowei, Czerniecki, Brian, Spitz, Francis, Schuchter, Lynn, Elder, David

“…The majority of invasive primary melanomas are thin (< or = 1.00 mm). Since the current staging system imperfectly predicts outcome in patients with such…”
Get full text

Biologic and Prognostic Significance of Dermal Ki67 Expression, Mitoses, and Tumorigenicity in Thin Invasive Cutaneous Melanoma by GIMOTTY, Phyllis A, VAN BELLE, Patricia, GUERRY, Dupont, ELDER, David E, MURRY, Todd, MONTONE, Kathleen T, XIAOWEI XU, HOTZ, Susan, RAINES, Shane, MING, Michael E, WAHL, Peter

“…Tumor cell proliferation is a central feature of melanoma progression. In this study, we characterized three biomarkers of proliferation (Ki67 expression,…”
Get full text

Association between the anatomic distribution of melanoma and sex by Clark, Lily N., MD, Shin, Daniel B., BA, Troxel, Andrea B., ScD, Khan, Shahbaz, MBBS, MPH, Sober, Arthur J., MD, Ming, Michael E., MD, MSCE

“…Background Anatomic distribution of melanoma, thought to be different between men and women, has not been studied in the United States since the 1970s,…”
Get full text

Lymphatic invasion revealed by multispectral imaging is common in primary melanomas and associates with prognosis by Xu, Xiaowei, MD, PhD, Gimotty, Phyllis A., PhD, Guerry, DuPont, MD, Karakousis, Giorgos, MD, Van Belle, Patricia, PhD, Liang, Haohai, MD, Montone, Katharine, MD, Pasha, Terry, BS, Ming, Michael E., MD, Acs, Geza, MD, PhD, Feldman, Michael, MD, PhD, Barth, Stephen, MS, Hammond, Rachel, MS, Elenitsas, Rosalie, MD, Zhang, Paul J., MD, Elder, David E., MBChB

“…Summary Lymphatic invasion by tumor cells has been noted infrequently in primary melanomas. Our primary hypotheses were that using immunohistochemical markers…”
Get full text

Shedding Light on Disparities in Melanoma Care by Chu, Emily Y., Takeshita, Junko, Ming, Michael E.

“…The article by Shah et al. (2021) published in the Journal of Investigative Dermatology adds to the growing body of literature on disparities in melanoma care…”
Get full text

Skin surveillance intentions among family members of patients with melanoma by Coups, Elliot J, Manne, Sharon L, Jacobsen, Paul B, Ming, Michael E, Heckman, Carolyn J, Lessin, Stuart R

“…First-degree relatives of individuals diagnosed with melanoma are at increased disease risk. However, many first-degree relatives do not receive a periodic…”
Get full text

Factors associated with adherence to skin self-examination recommendations for melanoma patients: A prospective cohort study by Nugent, Shannon, Deitermann, Annika M., Lin, Stephanie K., Lewis, Daniel J., Shin, Daniel B., Ming, Michael E.

Get full text

Impact of 8th edition AJCC staging changes on sentinel lymph node biopsy practices in melanoma by Tortorello, Gabriella N., Shafique, Neha, Dheer, Anushka, Chu, Emily Y., Ming, Michael E., Miura, John T., Karakousis, Giorgos C.

Get full text

Association Between Metastatic Melanoma Response to Checkpoint Inhibitor Therapy and Tumor-Infiltrating Lymphocyte Classification on Primary Cutaneous Melanoma Biopsies by Stephens, Michael R, Aderbigbe, Oyinade, Xu, Wei, Karakousis, Giorgos C, Ming, Michael E, Chu, Emily Y

Get more information

Pathologic characteristics and clinical outcomes of primary dermal melanoma by Tortorello, Gabriella N., Li, Eric H., Sharon, Cimarron E., Shafique, Neha, Chu, Emily Y., Ming, Michael E., Karakousis, Giorgos C.

Get full text

Outcomes of Merkel Cell Carcinoma in the Era of Immune Checkpoint Blockade by Shafique, Neha, Dheer, Anushka, Tortorello, Gabriella, Chu, Emily Y., Ming, Michael E., Miura, John T., Karakousis, Giorgos C.

Get full text

The impact of the COVID-19 pandemic on the presentation status of newly diagnosed melanoma: A single institution experience by Shannon, Adrienne B., Sharon, Cimarron E., Straker, Richard J., Miura, John T., Ming, Michael E., Chu, Emily Y., Karakousis, Giorgos C.

Get full text

Sentinel lymph node biopsy in patients with clinical stage IIB/C cutaneous melanoma: A national cohort study by Straker, Richard J., Sharon, Cimarron E., Chu, Emily Y., Miura, John T., Ming, Michael E., Karakousis, Giorgos C.

“…Approval of adjuvant anti-programmed cell death protein 1 therapy for pathologic stage IIB/C cutaneous melanoma has led some to question the role of sentinel…”
Get full text

Evaluation of the Merits and Limitations of Evidence-Based Medicine by Chu, Emily Y, Stein, Jennifer A, Ming, Michael E

Get more information

Eruptive disseminated Spitz nevi by Levy, Ross M., MD, Ming, Michael E., MD, MSCE, Shapiro, Michael, MD, Tucker, Margaret, MD, Guerry, DuPont, MD, Cirillo-Hyland, Victoria A., MD, Elenitsas, Rosalie, MD

“…Eruptive disseminated Spitz nevi represent an extremely rare variant of Spitz nevi, with only 13 previous cases reported in the literature. We describe a…”
Get full text

Prognostic Gene Expression Profiling in Cutaneous Melanoma: Identifying the Knowledge Gaps and Assessing the Clinical Benefit by Grossman, Douglas, Okwundu, Nwanneka, Bartlett, Edmund K, Marchetti, Michael A, Othus, Megan, Coit, Daniel G, Hartman, Rebecca I, Leachman, Sancy A, Berry, Elizabeth G, Korde, Larissa, Lee, Sandra J, Bar-Eli, Menashe, Berwick, Marianne, Bowles, Tawnya, Buchbinder, Elizabeth I, Burton, Elizabeth M, Chu, Emily Y, Curiel-Lewandrowski, Clara, Curtis, Julia A, Daud, Adil, Deacon, Dekker C, Ferris, Laura K, Gershenwald, Jeffrey E, Grossmann, Kenneth F, Hu-Lieskovan, Siwen, Hyngstrom, John, Jeter, Joanne M, Judson-Torres, Robert L, Kendra, Kari L, Kim, Caroline C, Kirkwood, John M, Lawson, David H, Leming, Philip D, Long, Georgina V, Marghoob, Ashfaq A, Mehnert, Janice M, Ming, Michael E, Nelson, Kelly C, Polsky, David, Scolyer, Richard A, Smith, Eric A, Sondak, Vernon K, Stark, Mitchell S, Stein, Jennifer A, Thompson, John A, Thompson, John F, Venna, Suraj S, Wei, Maria L, Swetter, Susan M

“…Use of prognostic gene expression profile (GEP) testing in cutaneous melanoma (CM) is rising despite a lack of endorsement as standard of care. To develop…”
Get more information